Literature DB >> 23733619

Neurocognitive and behavioral outcomes in Latino childhood cancer survivors.

Sunita K Patel1, Tracy T Y Lo, Jessica M Dennis, Smita Bhatia.   

Abstract

BACKGROUND: Children with brain tumors and leukemia are at risk for neurocognitive and behavioral late effects due to central nervous system-directed therapies. Few studies have examined these outcomes in ethnic minority samples, despite speculation that socio-demographic factors may increase vulnerability for adverse neurobehavioral outcomes. We evaluated the neurocognitive and behavioral outcomes and their impact on the health-related quality of life in survivors of childhood cancer drawn from Latino families in the Los Angeles region. PROCEDURE: Using culturally-relevant recruitment strategies, 73 predominantly Spanish-speaking parents of pediatric brain tumor or leukemia survivors completed standardized questionnaires, including the Conners parent-report and the Bidimensional Acculturation Scales. Clinical and socio-demographic factors influencing the development of neurocognitive and behavioral dysfunction were examined.
RESULTS: Approximately 50% of the children placed at or above the "elevated" level for difficulties with attention, school-based learning, and peer relations. Younger age at diagnosis significantly predicted dysfunction in inattention, learning problems, and hyperactivity/impulsivity. Children whose parents were less adherent to the non-Hispanic white culture were more likely to have problems with peer relations and executive functioning. HRQL was significantly lower in survivors with neurocognitive and behavioral dysfunction relative to those with normal range scores on the Conners scale.
CONCLUSIONS: In addition to the child's age at diagnosis, acculturation appears to predict select neurocognitive and behavioral outcomes in this socio-demographically homogeneous sample of Latino families. Further research is needed to understand the interaction of ethnic and cultural factors with therapeutic exposures in determining the adverse neurobehavioral outcomes, so as to optimally design interventions.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Latino; childhood cancer; health disparities; late effects; neurocognitive

Mesh:

Year:  2013        PMID: 23733619      PMCID: PMC3776597          DOI: 10.1002/pbc.24608

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

1.  Meeting the health promotion needs of Hispanic communities. Policy and Research, National Coalition of Hispanic Health and Human Services Organizations (COSSMHO).

Authors: 
Journal:  Am J Health Promot       Date:  1995 Mar-Apr

Review 2.  Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.

Authors:  Paul C Nathan; Sunita K Patel; Kimberley Dilley; Robert Goldsby; Jeanne Harvey; Chad Jacobsen; Nina Kadan-Lottick; Karen McKinley; Anne K Millham; Ida Moore; M Fatih Okcu; Catherine L Woodman; Pim Brouwers; F Daniel Armstrong
Journal:  Arch Pediatr Adolesc Med       Date:  2007-08

Review 3.  Effective recruitment and retention of minority research participants.

Authors:  Antronette K Yancey; Alexander N Ortega; Shiriki K Kumanyika
Journal:  Annu Rev Public Health       Date:  2006       Impact factor: 21.981

4.  A simulation study of the number of events per variable in logistic regression analysis.

Authors:  P Peduzzi; J Concato; E Kemper; T R Holford; A R Feinstein
Journal:  J Clin Epidemiol       Date:  1996-12       Impact factor: 6.437

5.  Factors associated with health-related quality of life in pediatric cancer survivors.

Authors:  Kathleen A Meeske; Sunita K Patel; Stephanie N Palmer; Mary B Nelson; Aimee M Parow
Journal:  Pediatr Blood Cancer       Date:  2007-09       Impact factor: 3.167

6.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

7.  Predictors of independent living status in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Alicia Kunin-Batson; Nina Kadan-Lottick; Liang Zhu; Cheryl Cox; Veronica Bordes-Edgar; Deo Kumar Srivastava; Lonnie Zeltzer; Leslie L Robison; Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2011-02-03       Impact factor: 3.167

8.  Intensity of CNS treatment for pediatric cancer: prediction of social outcomes in survivors.

Authors:  Kathryn Vannatta; Cynthia A Gerhardt; Robert J Wells; Robert B Noll
Journal:  Pediatr Blood Cancer       Date:  2007-10-15       Impact factor: 3.167

9.  Late effects in long-term survivors after treatment for childhood acute leukemia.

Authors:  Theresa B Haddy; Revonda B Mosher; Gregory H Reaman
Journal:  Clin Pediatr (Phila)       Date:  2009-03-04       Impact factor: 1.168

10.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

View more
  7 in total

1.  Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status.

Authors:  Kimberly P Raghubar; Jessica Orobio; M Douglas Ris; Andrew M Heitzer; Alexandra Roth; Austin L Brown; M Fatih Okcu; Murali Chintagumpala; David R Grosshans; Arnold C Paulino; Anita Mahajan; Lisa S Kahalley
Journal:  Pediatr Blood Cancer       Date:  2019-05-27       Impact factor: 3.167

2.  Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy.

Authors:  Alexandra K Roth; M Douglas Ris; Jessica Orobio; Judy Xue; Anita Mahajan; Arnold C Paulino; David Grosshans; M Fatih Okcu; Murali Chintagumpala; Lisa S Kahalley
Journal:  Pediatr Blood Cancer       Date:  2019-11-17       Impact factor: 3.167

3.  Implementing the psychosocial standards in pediatric cancer: Current staffing and services available.

Authors:  Michele A Scialla; Kimberly S Canter; Fang Fang Chen; E Anders Kolb; Eric Sandler; Lori Wiener; Anne E Kazak
Journal:  Pediatr Blood Cancer       Date:  2017-05-19       Impact factor: 3.167

4.  Social-ecological predictors of school functioning in Hispanic children treated for cancer with central nervous system-directed therapies.

Authors:  Sunita K Patel; Christopher Johansen; Abigail Onderwyzer Gold; Nicole Delgado; Sandra Xu; Jessica Dennis
Journal:  Pediatr Blood Cancer       Date:  2020-07-31       Impact factor: 3.167

5.  Adaptation of an Intervention to Reduce Disparities in School HRQOL for Latino Childhood Cancer Survivors.

Authors:  Sunita K Patel; Leticia Miranda; Nicole Delgado; Nicolas Barreto; Anne Nolty; Natalie C Kelly; Karla Wilson; Debbie Toomey; Anna Pawlowska
Journal:  J Pediatr Psychol       Date:  2020-09-01

6.  Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.

Authors:  Kristina K Hardy; Leanne Embry; John A Kairalla; Shanjun Helian; Meenakshi Devidas; Daniel Armstrong; Stephen Hunger; William L Carroll; Eric Larsen; Elizabeth A Raetz; Mignon L Loh; Wenjian Yang; Mary V Relling; Robert B Noll; Naomi Winick
Journal:  J Clin Oncol       Date:  2017-07-03       Impact factor: 44.544

7.  Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.

Authors:  Kristen J Stefanski; Julia S Anixt; Pamela Goodman; Katherine Bowers; Wendy Leisenring; K Scott Baker; Karen Burns; Rebecca Howell; Stella Davies; Leslie L Robison; Gregory T Armstrong; Kevin R Krull; Christopher Recklitis
Journal:  J Natl Cancer Inst       Date:  2021-04-06       Impact factor: 13.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.